KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) FCF Margin (2016 - 2025)

Fulgent Genetics' FCF Margin history spans 10 years, with the latest figure at 99.74% for Q4 2025.

  • For Q4 2025, FCF Margin fell 12761.0% year-over-year to 99.74%; the TTM value through Dec 2025 reached 38.49%, down 3170.0%, while the annual FY2025 figure was 38.49%, 3170.0% down from the prior year.
  • FCF Margin for Q4 2025 was 99.74% at Fulgent Genetics, down from 6.02% in the prior quarter.
  • Across five years, FCF Margin topped out at 65.3% in Q3 2021 and bottomed at 99.74% in Q4 2025.
  • The 5-year median for FCF Margin is 6.28% (2022), against an average of 7.4%.
  • The largest annual shift saw FCF Margin skyrocketed 7555bps in 2021 before it plummeted -12761bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 28.25% in 2021, then skyrocketed by 49bps to 42.07% in 2022, then crashed by -60bps to 16.77% in 2023, then surged by 66bps to 27.87% in 2024, then crashed by -458bps to 99.74% in 2025.
  • Per Business Quant, the three most recent readings for FLGT's FCF Margin are 99.74% (Q4 2025), 6.02% (Q3 2025), and 45.23% (Q2 2025).